Romnee Clark

  • 307 Citations
  • 11 h-Index
19942016

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Romnee Clark is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants

CANCER CENTER SUPPORT GRANT

Zhang, Z., Clark, R., Perkins, S., Abonour, R., Srour, E., Dunn, K., Loehrer, P., Yiannoutsos, C., Field, L., Williams, S., Croop, J., Williams, D., Hawes, J., Jung, S., Cripe, L., Cripe, L., Hanna, N., Liu, Y., Miller, K., Broxmeyer, H., Korc, M., Rawl, S., Champion, V., Nakshatri, H., Pollok, K. & Kelley, M.

National Institutes of Health

9/22/998/31/19

Project: Research project

  • Publications

    • 307 Citations
    • 11 h-Index
    • 11 Article
    • 1 Letter

    Phase I study of lenalidomide and sorafenib inpatients with advanced hepatocellular carcinoma

    Shahda, S., Loehrer, P., Clark, R., Spittler, A. J., Althouse, S. K. & Chiorean, E. G., Jun 1 2016, In : Oncologist. 21, 6, p. 664-665 2 p.

    Research output: Contribution to journalArticle

  • 4 Scopus citations

    Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in locally advanced unresectable pancreatic cancer

    Chiorean, E. G., Schneider, B. P., Akisik, F. M., Perkins, S. M., Anderson, S., Johnson, C. S., Dewitt, J., Helft, P., Clark, R., Johnston, E. L., Spittler, A. J., Deluca, J., Bu, G., Shahda, S., Loehrer, P. J., Sandrasegaran, K. & Cardenes, H. R., Jun 1 2014, In : International Journal of Radiation Oncology Biology Physics. 89, 2, p. 284-291 8 p.

    Research output: Contribution to journalArticle

  • 19 Scopus citations

    Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53

    Chiorean, E. G., Sanghani, S., Schiel, M. A., Yu, M., Burns, M., Tong, Y., Hinkle, D. T., Coleman, N., Robb, B., Leblanc, J., Clark, R., Bufill, J., Curie, C., Loehrer, P. J. & Cardenes, H., Jul 1 2012, In : Cancer Chemotherapy and Pharmacology. 70, 1, p. 25-32 8 p.

    Research output: Contribution to journalArticle

  • 16 Scopus citations

    Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): A phase I/II study from the hoosier oncology group

    Jalal, S., Waterhouse, D., Edelman, M. J., Nattam, S., Ansari, R., Koneru, K., Clark, R., Richards, A., Wu, J., Yu, M., Bottema, B., White, A. & Hanna, N., Nov 2009, In : Journal of Thoracic Oncology. 4, 11, p. 1420-1424 5 p.

    Research output: Contribution to journalArticle

  • 17 Scopus citations

    A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer

    Llombart-Cussac, A., Martin, M., Harbeck, N., Anghel, R. M., Eniu, A. E., Verrill, M. W., Neven, P., De Grève, J., Melemed, A. S., Clark, R., Simms, L., Kaiser, C. J. & Ma, D., Jun 15 2007, In : Clinical Cancer Research. 13, 12, p. 3652-3659 8 p.

    Research output: Contribution to journalArticle

  • 24 Scopus citations